Literature DB >> 9491786

Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation.

S E Damon1, K L Haugk, R S Birnbaum, L S Quinn.   

Abstract

Recent studies have indicated that the insulin-like growth factors (IGFs) stimulate skeletal myoblast proliferation and differentiation. However, the question of whether IGFs are required for myoblast differentiation has not been resolved. To address this issue directly, we used a retroviral vector (LBP4SN) to develop a subline of mouse C2 myoblasts (C2-BP4) that constitutively overexpress IGF binding protein-4 (IGFBP-4). A control C2 myoblast subline (C2-LNL6) was also developed by using the LNL6 control retroviral vector. C2-BP4 myoblasts expressed sixfold higher levels of IGFBP-4 protein than C2-LNL6 myoblasts. 125I-IGF-I cross linking indicated that IGFBP-4 overexpression reduced IGF access to the type-1 IGF receptor tenfold. At low plating densities, myoblast proliferation was inhibited, and myoblast differentiation was abolished in C2-BP4 cultures compared with C2-LNL6 cultures. At high plating densities in which nuclear numbers were equal in the two sets of cultures, C2-BP4 myoblast differentiation was inhibited completely. Differentiation was restored in C2-BP4 cells by treatment with high levels of exogenous IGF-I or with des(1-3)IGF-I, an analog of IGF-I with reduced affinity for IGFBPs. These findings confirm the hypothesis that positive differentiation signals from the IGFs are necessary for C2 myoblast differentiation, and they suggest that the present model of myogenic differentiation, which involves only negative external control of differentiation by mitogens, may be incomplete.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491786     DOI: 10.1002/(SICI)1097-4652(199804)175:1<109::AID-JCP12>3.0.CO;2-6

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism.

Authors:  Ashok Kumar; Subburaman Mohan; Jacqueline Newton; Mark Rehage; Kiet Tran; David J Baylink; Xuezhong Qin
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  A change in nuclear pore complex composition regulates cell differentiation.

Authors:  Maximiliano A D'Angelo; J Sebastian Gomez-Cavazos; Arianna Mei; Daniel H Lackner; Martin W Hetzer
Journal:  Dev Cell       Date:  2012-01-19       Impact factor: 12.270

Review 3.  Biological approaches to improve skeletal muscle healing after injury and disease.

Authors:  Burhan Gharaibeh; Yuri Chun-Lansinger; Tanya Hagen; Sheila Jean McNeill Ingham; Vonda Wright; Freddie Fu; Johnny Huard
Journal:  Birth Defects Res C Embryo Today       Date:  2012-03

4.  Ganoderma microsporum immunomodulatory protein, GMI, promotes C2C12 myoblast differentiation in vitro via upregulation of Tid1 and STAT3 acetylation.

Authors:  Wan-Huai Teo; Jeng-Fan Lo; Yu-Ning Fan; Chih-Yang Huang; Tung-Fu Huang
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

5.  Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.

Authors:  Y E Smith; S Toomey; S Napoletano; G Kirwan; C Schadow; A J Chubb; J H Mikkelsen; C Oxvig; J H Harmey
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.